Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Thymectomy in multiple sclerosis. Two preliminary trials.

T B Ferguson, D B Clifford, E B Montgomery

    The Journal of Thoracic and Cardiovascular Surgery
    |January 1, 1983
    PubMed
    Summary
    This summary is machine-generated.

    Related Concept Videos

    You might also read

    Related Articles

    Articles linked to this work by shared authors, journal, and citation graph.

    Sort by
    Same author

    Dominantly Inherited Alzheimer Network Trials Unit (DIAN-TU): Trial Satisfaction and Attitudes towards Future Clinical Trials.

    The journal of prevention of Alzheimer's disease..·2024
    Same author

    Checkpoint therapy for progressive multifocal leukoencephalopathy: pointless?

    European journal of neurology·2020
    Same author

    Cerebrospinal Fluid Ceruloplasmin, Haptoglobin, and Vascular Endothelial Growth Factor Are Associated with Neurocognitive Impairment in Adults with HIV Infection.

    Molecular neurobiology·2018
    Same author

    Brain morphometric correlates of metabolic variables in HIV: the CHARTER study.

    Journal of neurovirology·2014
    Same author

    Characterizing HIV medication adherence for virologic success among individuals living with HIV/AIDS: Experience with the CNS HIV Antiretroviral Therapy Effects Research (CHARTER) cohort.

    Journal of HIV/AIDS & social services·2014
    Same author

    Selective loss of myelin proteins during autolysis.

    Neurochemical research·2013
    Same journal

    Pushing the Age Limit: Mitral Valve Surgery Is Safe and Effective in Octogenarians.

    The Journal of thoracic and cardiovascular surgery·2026
    Same journal

    Bridging Pediatric and Young Adult Cancer Survivorship: Defining the Thoracic Surgeon's Role Across the Continuum.

    The Journal of thoracic and cardiovascular surgery·2026
    Same journal

    Beyond compensatory expansion: Extending 3-dimensional computed tomography volumetry toward lung-preserving local therapy.

    The Journal of thoracic and cardiovascular surgery·2026
    Same journal

    A CALL FOR STANDARDIZATION OF HYBRID ARCH FROZEN ELEPHANT TRUNK OUTCOMES REPORTING.

    The Journal of thoracic and cardiovascular surgery·2026
    Same journal

    Pediatric Mitral Valve Surgery: Current Practice from the European Congenital Heart Surgeons Association Congenital Database Analysis.

    The Journal of thoracic and cardiovascular surgery·2026
    Same journal

    Rethinking Failure to Rescue in Cardiac Surgery.

    The Journal of thoracic and cardiovascular surgery·2026
    See all related articles

    Thymectomy combined with azathioprine therapy showed significant improvements in multiple sclerosis (MS) patients. Patients receiving thymectomy alone did not demonstrate similar benefits compared to controls.

    Area of Science:

    • Neuroimmunology
    • Surgical Neurology

    Background:

    • Multiple Sclerosis (MS) is a chronic autoimmune disease affecting the central nervous system.
    • The role of thymectomy and immunosuppressive therapies in MS management remains under investigation.
    • Azathioprine's efficacy in MS is considered questionable by several studies.

    Purpose of the Study:

    • To evaluate the clinical efficacy of thymectomy in multiple sclerosis patients.
    • To compare outcomes between MS patients undergoing thymectomy with or without azathioprine therapy.
    • To assess the impact of thymectomy on neurological function, disability status, and exacerbation rates.

    Main Methods:

    • Two preliminary trials involving 35 multiple sclerosis patients undergoing thymectomy.
    • Group I: Thymectomy with 1 year of azathioprine therapy.

    Related Experiment Videos

  • Group II: Thymectomy without azathioprine therapy.
  • Clinical neurologic status assessed yearly post-operation, compared against matched controls.
  • Utilized Kurtzke scales for functional and disability status assessment.

    • Main Results:

    • Group I patients demonstrated significant improvements in overall functional status and pyramidal functions at 1 and 2 years post-thymectomy.
    • A statistically significant improvement in disability status and a decrease in exacerbations were observed in relapsing-remitting MS patients within Group I.
    • Group II patients showed no significant favorable trends compared to control patients; functional groups, disability status, and exacerbations remained similar.

    Conclusions:

    • The combination of thymectomy and azathioprine therapy may offer a synergistic benefit in managing multiple sclerosis.
    • Thymectomy alone did not yield significant clinical improvements in this preliminary study.
    • Further investigation, including a third follow-up year, is warranted to confirm these findings and potentially initiate a formal pilot study.